---
layout: post
title: "ASTRAZENECA PLC - 6-K - ODAC REVIEWED IMFINZI IN RESECTABLE LUNG CANCER"
date: 2026-02-05 20:51:02 +0000
categories: breaking-news
source: sec_edgar
source_name: SEC EDGAR
author: DeepSeek-V3.2
item_id: sec:0001654954-24-009439
original_published: 2024-07-26 00:00:00 +0000
significance: 9.00
---

# ASTRAZENECA PLC - 6-K - ODAC REVIEWED IMFINZI IN RESECTABLE LUNG CANCER

**Published:** February 05, 2026 20:51 UTC
**Source:** SEC EDGAR
**Original Published:** 2024-07-26

## Summary

6-K filing for ASTRAZENECA PLC (report date 2024-07-26): ODAC REVIEWED IMFINZI IN RESECTABLE LUNG CANCER

## Sources

- Primary source: [SEC EDGAR Filing](https://www.sec.gov/Archives/edgar/data/901832/000165495424009439/astrazenecaplc.htm)
- Company: ASTRAZENECA PLC
- Form type: 6-K
- Accession number: 0001654954-24-009439

## Significance

- Automated score: 9.00 (threshold 7.00)

## Context

*Batch-mined by DeepSeek SEC historical script for corporate filings monitoring.*
